Skip to main content

and
  1. Article

    Open Access

    A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation

    Aberrant alterations of ERBB receptor tyrosine kinases lead to tumorigenesis. Single agent therapy targeting EGFR or HER2 has shown clinical successes, but drug resistance often develops due to aberrant or co...

    Sarina A. Piha-Paul, Chieh Tseng, Hai T. Tran in Cancer Chemotherapy and Pharmacology (2023)

  2. Article

    Open Access

    The role of the aging microenvironment on the fate of PDGFRβ lineage cells in skeletal muscle repair

    During aging, perturbation of muscle progenitor cell (MPC) constituents leads to progressive loss of muscle mass and accumulation of adipose and fibrotic tissue. Mesenchymal stem cells (MSCs) give rise to adip...

    Ai** Lu, Chieh Tseng, ** Guo, Zhanguo Gao in Stem Cell Research & Therapy (2022)

  3. Article

    Open Access

    Heterogenetic parabiosis between healthy and dystrophic mice improve the histopathology in muscular dystrophy

    Duchenne muscular dystrophy (DMD) is a progressive muscle disease, characterized by mutations in the X-linked dystrophin, that has several therapeutic options but no curative treatment. Transplantation of musc...

    Ai** Lu, ** Guo, Liang Wang, Chieh Tseng, Matthieu Huard in Scientific Reports (2020)

  4. Article

    Open Access

    CXCL1 mediates obesity-associated adipose stromal cell trafficking and function in the tumour microenvironment

    White adipose tissue (WAT) overgrowth in obesity is linked with increased aggressiveness of certain cancers. Adipose stromal cells (ASCs) can become mobilized from WAT, recruited by tumours and promote cancer ...

    Tao Zhang, Chieh Tseng, Yan Zhang, Olga Sirin, Paul G. Corn in Nature Communications (2016)

  5. No Access

    Article

    The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming

    Extensive reprogramming of cellular energy metabolism is a hallmark of cancer. Despite its importance, the molecular mechanism controlling this tumour metabolic shift remains not fully understood. Here we show...

    Liem Phan, **-Chieh Chou, Guermarie Velazquez-Torres in Nature Communications (2015)

  6. No Access

    Article

    CSN6 drives carcinogenesis by positively regulating Myc stability

    Cullin-RING ubiquitin ligases (CRLs) are critical in ubiquitinating Myc, while COP9 signalosome (CSN) controls neddylation of Cullin in CRL. The mechanistic link between Cullin neddylation and Myc ubiquitinati...

    Jian Chen, Ji-Hyun Shin, Ruiying Zhao, Liem Phan, Hua Wang in Nature Communications (2014)

  7. No Access

    Article

    A peptide probe for targeted brown adipose tissue imaging

    The presence of brown adipose tissue responsible for thermogenic energy dissipation has been revealed in adult humans and has high clinical importance. Owing to limitations of current methods for brown adipose...

    Ali Azhdarinia, Alexes C. Daquinag, Chieh Tseng, Sukhen C. Ghosh in Nature Communications (2013)

  8. No Access

    Chapter

    Adipose Tissue-Derived Progenitor Cells and Cancer

    Obesity, a condition of white adipose tissue (WAT) overgrowth and perturbation of system metabolic homeostasis, is a significant risk factor for cancer mortality. The mechanisms underlying the obesity-cancer l...

    Chieh Tseng, Mikhail G. Kolonin Ph.D. in Angiogenesis in Adipose Tissue (2013)